Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice

English version České info

Influenza A virus causes annual epidemics which affect millions of people worldwide. A recent Influenza pandemic brought new awareness over the health impact of the disease. It is thought that a severe inflammatory response against the virus contributes to disease severity and death. Therefore, modulating the effects of inflammatory mediators may represent a new therapy against Influenza infection. Platelet activating factor (PAF) receptor (PAFR) deficient mice were used to evaluate the role of the gene in a model of experimental infection with Influenza A/WSN/33 H1N1 or a reassortant Influenza A H3N1 subtype. The following parameters were evaluated: lethality, cell recruitment to the airways, lung pathology, viral titers and cytokine levels in lungs. The PAFR antagonist PCA4248 was also used after the onset of flu symptoms. Absence or antagonism of PAFR caused significant protection against flu-associated lethality and lung injury. Protection was correlated with decreased neutrophil recruitment, lung edema, vascular permeability and injury. There was no increase of viral load and greater recruitment of NK1.1⁺ cells. Antibody responses were similar in WT and PAFR-deficient mice and animals were protected from re-infection. Influenza infection induces the enzyme that synthesizes PAF, lyso-PAF acetyltransferase, an effect linked to activation of TLR7/8. Therefore, it is suggested that PAFR is a disease-associated gene and plays an important role in driving neutrophil influx and lung damage after infection of mice with two subtypes of Influenza A. Further studies should investigate whether targeting PAFR may be useful to reduce lung pathology associated with Influenza A virus infection in humans.

Vyšlo v časopise: Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001171
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001171

Souhrn

Zdroje

1. BouvierNM

PaleseP

2008 The biology of influenza viruses. Vaccine 26 Suppl 4 D49 53

2. MichaelisM

DoerrHW

CinatlJJr

2009 Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol 198 175 183

3. WhiteNJ

WebsterRG

GovorkovaEA

UyekiTM

2009 What is the optimal therapy for patients with H5N1 influenza? PLoS Med 6 e1000091

4. RufBR

SzucsT

2009 Reducing the burden of influenza-associated complications with antiviral therapy. Infection 37 186 196

5. AokiFY

MacleodMD

PaggiaroP

CarewiczO

El SawyA

2003 Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 51 123 129

6. KisoM

MitamuraK

Sakai-TagawaY

ShiraishiK

KawakamiC

2004 Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364 759 765

7. FedsonDS

2009 Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Respi Viruses 3 129 142

8. WangJP

BowenGN

PaddenC

CernyA

FinbergRW

2008 Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112 2028 2034

9. OpitzB

RejaibiA

DauberB

EckhardJ

VinzingM

2007 IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9 930 938

10. AllenIC

ScullMA

MooreCB

HollEK

McElvania-TeKippeE

2009 The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 556 565

11. ThomasPG

DashP

AldridgeJRJr

EllebedyAH

ReynoldsC

2009 The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30 566 575

12. Le GofficR

PothlichetJ

VitourD

FujitaT

MeursE

2007 Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178 3368 3372

13. JulkunenI

MelenK

NyqvistM

PirhonenJ

SarenevaT

2000 Inflammatory responses in influenza A virus infection. Vaccine 19 Suppl 1 S32 37

14. KohlmeierJE

WoodlandDL

2009 Immunity to respiratory viruses. Annu Rev Immunol 27 61 82

15. FujisawaH

2008 Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 82 2772 2783

16. HartshornKL

LiouLS

WhiteMR

KazhdanMM

TauberJL

1995 Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol 154 3952 3960

17. TuvimMJ

EvansSE

ClementCG

DickeyBF

GilbertBE

2009 Augmented lung inflammation protects against influenza A pneumonia. PLoS One 4 e4176

18. ChenXJ

SethS

YueG

KamatP

CompansRW

2004 Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol 287 L366 373

19. ShindouH

HishikawaD

NakanishiH

HarayamaT

IshiiS

2007 A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. J Biol Chem 282 6532 6539

20. IshiiS

ShimizuT

2000 Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39 41 82

21. UhligS

GoggelR

EngelS

2005 Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. Pharmacol Rep 57 Suppl 206 221

22. MontrucchioG

AlloattiG

CamussiG

2000 Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80 1669 1699

23. SouzaDG

PinhoV

SoaresAC

ShimizuT

IshiiS

2003 Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol 139 733 740

24. BedirliA

GokahmetogluS

SakrakO

SoyuerI

InceO

2004 Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur Surg Res 36 136 141

25. LandgrafRG

NossiDF

SiroisP

JancarS

2007 Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Prostaglandins Leukot Essent Fatty Acids 77 163 172

26. PrescottSM

ZimmermanGA

StafforiniDM

McIntyreTM

2000 Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69 419 445

27. ImaiY

KubaK

NeelyGG

Yaghubian-MalhamiR

PerkmannT

2008 Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133 235 249

28. CroweCR

ChenK

PociaskDA

AlcornJF

KrivichC

2009 Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183 5301 5310

29. van der SluijsKF

van EldenLJ

NijhuisM

SchuurmanR

FlorquinS

2006 Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 290 L194 199

30. LinKL

SuzukiY

NakanoH

RamsburgE

GunnMD

2008 CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180 2562 2572

31. SakaiS

KawamataH

MantaniN

KogureT

ShimadaY

2000 Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J Virol 74 2472 2476

32. SekiM

KohnoS

NewsteadMW

ZengX

BhanU

Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol 184 1410 1418

33. BarnardDL

2009 Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 82 A110 122

34. PerroneLA

PlowdenJK

Garcia-SastreA

KatzJM

TumpeyTM

2008 H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4 e1000115

35. LeeYM

HybertsonBM

ChoHG

RepineJE

2002 Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. J Lab Clin Med 140 312 319

36. GabrijelcicJ

AcunaA

ProfitaM

PaternoA

ChungKF

2003 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. Eur Respir J 22 290 297

37. WhiteMR

CrouchE

VesonaJ

TackenPJ

BatenburgJJ

2005 Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol 289 L606 616

38. TumpeyTM

Garcia-SastreA

TaubenbergerJK

PaleseP

SwayneDE

2005 Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79 14933 14944

39. McNameeLA

HarmsenAG

2006 Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 74 6707 6721

40. ColamussiML

WhiteMR

CrouchE

HartshornKL

1999 Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 93 2395 2403

41. McCullersJA

RehgJE

2002 Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 186 341 350

42. McCullersJA

IversonAR

McKeonR

MurrayPJ

2008 The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis 40 11 17

43. ChignardM

BalloyV

2000 Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 279 L1083 1090

44. BruderD

SrikiatkhachornA

EnelowRI

2006 Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 19 147 155

45. CulleyFJ

2009 Natural killer cells in infection and inflammation of the lung. Immunology 128 151 163

46. MandelboimO

LiebermanN

LevM

PaulL

ArnonTI

2001 Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 1055 1060

47. MandiY

FarkasG

KoltaiM

BeladiI

Mencia-HuertaJM

1989 The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Immunology 67 370 374

48. JinY

DamajBB

MaghazachiAA

2005 Human resting CD16−, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. Eur J Immunol 35 2699 2708

49. SantiagoHC

Braga PiresMF

SouzaDG

RoffeE

CortesDF

2006 Platelet activating factor receptor-deficient mice present delayed interferon-gamma upregulation and high susceptibility to Leishmania amazonensis infection. Microbes Infect 8 2569 2577

50. McGillJ

HeuselJW

LeggeKL

2009 Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86 803 812

51. WatanabeY

HashimotoY

ShiratsuchiA

TakizawaT

NakanishiY

2005 Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun 337 881 886

52. HashimotoY

MokiT

TakizawaT

ShiratsuchiA

NakanishiY

2007 Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 178 2448 2457

53. SchmitzN

KurrerM

BachmannMF

KopfM

2005 Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79 6441 6448

54. MainesTR

SzretterKJ

PerroneL

BelserJA

BrightRA

2008 Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 225 68 84

55. NoursharghS

LarkinSW

DasA

WilliamsTJ

1995 Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood 85 2553 2558

56. YoungRE

ThompsonRD

NoursharghS

2002 Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules. Br J Pharmacol 137 1237 1246

57. MaratheGK

DaviesSS

HarrisonKA

SilvaAR

MurphyRC

1999 Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem 274 28395 28404

58. SouzaDG

FagundesCT

SousaLP

AmaralFA

SouzaRS

2009 Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci U S A 106 14138 14143

59. ZhengBJ

ChanKW

LinYP

ZhaoGY

ChanC

2008 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A 105 8091 8096

60. RussoRC

GuabirabaR

GarciaCC

BarcelosLS

RoffeE

2009 Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 40 410 421

61. HorvatJC

BeagleyKW

WadeMA

PrestonJA

HansbroNG

2007 Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176 556 564